1. Home
  2. XRTX vs IMTE Comparison

XRTX vs IMTE Comparison

Compare XRTX & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • IMTE
  • Stock Information
  • Founded
  • XRTX 2011
  • IMTE 2008
  • Country
  • XRTX Canada
  • IMTE Malaysia
  • Employees
  • XRTX N/A
  • IMTE N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • IMTE Consumer Electronics/Appliances
  • Sector
  • XRTX Health Care
  • IMTE Consumer Staples
  • Exchange
  • XRTX Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • XRTX 4.2M
  • IMTE 4.1M
  • IPO Year
  • XRTX N/A
  • IMTE N/A
  • Fundamental
  • Price
  • XRTX $0.89
  • IMTE $0.93
  • Analyst Decision
  • XRTX
  • IMTE
  • Analyst Count
  • XRTX 0
  • IMTE 0
  • Target Price
  • XRTX N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • XRTX 32.6K
  • IMTE 56.1K
  • Earning Date
  • XRTX 08-13-2025
  • IMTE 07-07-2025
  • Dividend Yield
  • XRTX N/A
  • IMTE N/A
  • EPS Growth
  • XRTX N/A
  • IMTE N/A
  • EPS
  • XRTX N/A
  • IMTE N/A
  • Revenue
  • XRTX N/A
  • IMTE $123,337.00
  • Revenue This Year
  • XRTX N/A
  • IMTE N/A
  • Revenue Next Year
  • XRTX N/A
  • IMTE N/A
  • P/E Ratio
  • XRTX N/A
  • IMTE N/A
  • Revenue Growth
  • XRTX N/A
  • IMTE 4.75
  • 52 Week Low
  • XRTX $0.80
  • IMTE $0.51
  • 52 Week High
  • XRTX $2.98
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 54.28
  • IMTE 28.78
  • Support Level
  • XRTX $0.80
  • IMTE $0.74
  • Resistance Level
  • XRTX $0.98
  • IMTE $1.03
  • Average True Range (ATR)
  • XRTX 0.05
  • IMTE 0.07
  • MACD
  • XRTX 0.01
  • IMTE -0.01
  • Stochastic Oscillator
  • XRTX 77.53
  • IMTE 44.96

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: